In Future It May Be Possible To Sniff Out The Side Effects Of Radiotherapy
2/25/2013
Researchers at the University of Warwick and The Royal Marsden NHS Foundation Trust have completed a study that may lead to clinicians being able to more accurately predict which patients will suffer from the side effects of radiotherapy...
Breast Cancer Tumour Growth Inhibited By OMEGA-3s
2/25/2013
A lifelong diet rich in omega-3 fatty acids can inhibit growth of breast cancer tumours by 30 per cent, according to new research from the University of Guelph. The study, published recently in the Journal of Nutritional Biochemistry, is believed to be the first to provide unequivocal evidence that omega-3s reduce cancer risk...
Breast Cancer Tumour Growth Inhibited By OMEGA-3s
2/25/2013
A lifelong diet rich in omega-3 fatty acids can inhibit growth of breast cancer tumours by 30 per cent, according to new research from the University of Guelph. The study, published recently in the Journal of Nutritional Biochemistry, is believed to be the first to provide unequivocal evidence that omega-3s reduce cancer risk...
Screening Could Avert 12,000 Lung Cancer Deaths Each Year In The United States
2/25/2013
Screening for lung cancer with low-dose computed tomography (LDCT) in all screening-eligible current and former smokers has the potential to avert approximately 12,000 lung cancer deaths each year in the United States. That is the conclusion of a new analysis published early online in CANCER, a peer-reviewed journal of the American Cancer Society...
Prostate Cancer Treated With High Dose Radioactive Pellets
2/25/2013
A new form of radiotherapy to treat prostate cancer is being used by doctors in Southampton, UK. Implanting radioactive pellets in prostate cancer patients which specifically target and eradicate the cancerous cells at the tumor site has proved to be very effective treatment...
Study Of Life's Tiniest Architects Could Lead To New Opportunity To Treat Cancers
2/25/2013
If a genome is the blueprint for life, then the chief architects are tiny slices of genetic material that orchestrate how we are assembled and function, Yale School of Medicine researchers report in the journal Developmental Cell...
Neuroblastomas With Sensitivity To BET Bromodomain Inhibitors May Be Identified By Biomarker
2/25/2013
Neuroblastoma, the most common malignant tumor of early childhood, is frequently associated with the presence of MYCN amplification, a genetic biomarker associated with poor prognosis. Researchers have determined that tumors containing MYCN amplification are sensitive to a new class of drugs, BET bromodomain inhibitors...
Omontys, Anemia Drug For Kidney Dialysis Patients, Recalled
2/25/2013
Omontys (peginesatide) Injection, a drug used for anemia treatment in kidney dialysis patients, has been recalled because of "serious, life-threatening or fatal hypersensitivity reactions", including anaphylaxis. The voluntary recall has been announced by Takeda Pharmaceutical Co. and Affymax Inc. The two companies have recalled all Omontys lots which are sold in 20mg and 10mg vials...
Use Of Catheters In Dialysis Linked With High Risk Of Infections, Heart Problems, And Death
2/25/2013
Review examines safety of different dialysis procedures to access the blood Highlights Dialysis patients using catheters to access the blood have the highest risks for death, infections, and cardiovascular events compared with patients using other types of vascular access...
Prostate Cancer Treated With High Dose Radioactive Pellets
2/25/2013
A new form of radiotherapy to treat prostate cancer is being used by doctors in Southampton, UK. Implanting radioactive pellets in prostate cancer patients which specifically target and eradicate the cancerous cells at the tumor site has proved to be very effective treatment...